2don MSN
The Supreme Court just made it easier for you to get cheaper generic drugs—with 1 major catch
A ruling in favor of generic drugmaker Hikma will make it harder for brand-name manufacturers to block cheaper alternatives.
A generic version of a breakthrough cystic fibrosis drug, manufactured in Bangladesh for a fraction of the American price, ...
Can the quality of generic drugs in the U.S. be made more consistent? One expert has some ideas on how to do it.
In an era of escalating healthcare costs, Americans increasingly face crucial decisions about their prescription medications. The choice between generic and brand-name drugs represents a significant ...
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options ...
June 17 (Reuters) - The U.S. Food and Drug Administration approved the first generic version of Roche's Xofluza, a single-dose flu medicine for certain patients aged five years and older, the ...
Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...
Generic drugs account for more than 90 percent of prescriptions filled in the United States. Recent studies have found concering variability in quality and safety America’s generic drug supply, most ...
Emory is the data editor at STAT. He’s a data journalist with a background in bioinformatics and molecular biology. You can reach Emory on Signal at jaspar.01. Elaine’s stories explore the boom in new ...
Generic drug manufacturers are facing increasing pressure from drug distributors, pharmacy benefit managers, and Indian competitors, leading to downward trends in generic drug prices. Which firms are ...
Generic drugs manufactured in India are linked to significantly more "severe adverse events" for patients who use them than equivalent drugs produced in the United States, a new study finds. These ...
A generic version of Wegovy is not currently available in the United States due to patents held by the manufacturer, Novo Nordisk, that may remain in effect until 2041. When the U.S. patent for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results